SEI Investments’s Tvardi Therapeutics TVRD Stock Holding History

SEI Investments’s Portfolio TVRD Stock Details TVRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-478	Closed	-$315K	–	2456
2019 Q3	$315K	Buy	+478	New	+$397K	﹤0.01%	2106
2018 Q3	–	Sell	-3	Closed	-$2K	–	3510
2018 Q2	$2K	Hold	3	–	–	﹤0.01%	3388
2018 Q1	$2K	Hold	3	–	–	﹤0.01%	3273
2017 Q4	$2K	Buy	+3	New	+$1.37K	﹤0.01%	3144
2017 Q1	–	Sell	-44	Closed	-$15K	–	3106
2016 Q4	$15K	Hold	44	–	–	﹤0.01%	2401
2016 Q3	$13K	Buy	+44	New	+$9.54K	﹤0.01%	2362

Other funds holding TVRD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCP

Rho Capital Partners New York $20.4M AUM

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

SEI Investments's TVRD Position: Q4 2019 in Review

SEI Investments sold out of Tvardi Therapeutics (TVRD) in Q4 2019, closing a stake of 478 shares — an estimated $315K sold.

SEI Investments first reported a position in TVRD in Q3 2016 and held it in 6 quarters. The position peaked at $315K in Q3 2019. 151 funds tracked by Wall St. Rank hold TVRD as of Q4 2019.

SEI Investments reported no remaining Tvardi Therapeutics position as of Q4 2019 after selling out during the quarter.
SEI Investments sold 478 Tvardi Therapeutics shares in Q4 2019, an estimated $315K.
SEI Investments first reported a position in Tvardi Therapeutics in Q3 2016 and held it in 6 quarters.
SEI Investments's Tvardi Therapeutics position peaked at $315K in Q3 2019.
151 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q4 2019.

Based on SEI Investments's 13F filing for Q4 2019, filed 6 Feb 2020.